TKT Gene
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TKT Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>TKT</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Transketolase</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>3p21.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>7086</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>177027</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000163798</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P29597</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>623 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>67.8 kDa</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/arm" style="color:#ef9a9a">ARM</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">55 edges</a></td>
</tr>
</table>
Tkt Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
TKT (Transketolase) encodes a crucial enzyme in the non-oxidative branch of the pentose phosphate pathway (PPP). Transketolase plays a vital role in cellular redox homeostasis through NADPH production and provides ribose-5-phosphate for nucleotide biosynthesis. TKT has been extensively studied in neurodegeneration due to its sensitivity to thiamine (vitamin B1) deficiency and its role in oxidative stress response. Dysregulated TKT function has been implicated in Alzheimer's Disease (AD), Wernicke-Korsakoff Syndrome, Parkinson's Disease (PD), and diabetic neuropathy. The gene is located on chromosome 3p21.1 and encodes a 623-amino acid protein. [@calingasan1995]
Protein Structure
Transketolase is a homodimeric enzyme with distinct functional domains:
- N-terminal domain (residues 1-320): Contains the binding site for donor substrate (sedoheptulose-7-P or xylulose-5-P)
- C-terminal domain (residues 321-623): Contains the binding site for acceptor substrate (ribose-5-P or glyceraldehyde-3-P)
- Thiamine pyrophosphate (TPP) binding pocket: Central catalytic site requiring TPP as cofactor
- Dimer interface: Required for enzyme stability and activity
The enzyme requires TPP and Mg²⁺/Ca²⁺ as essential cofactors.
Normal Function
Transketolase catalyzes transfers of two-carbon units in the non-oxidative PPP:
Key Reactions
Sedoheptulose-7-P + glyceraldehyde-3-P → ribose-5-P + fructose-6-P
Xylulose-5-P + glyceraldehyde-3-P → fructose-6-P + erythrose-4-P
- Connects glycolysis to PPP: Enables interconversion of glycolytic and PPP intermediates
- Ribose-5-P production: Essential for nucleotide and nucleic acid synthesis
- NADPH precursor: Supports reductive biosynthesis and antioxidant defense
- Erythrose-4-P production: Precursor for aromatic amino acid synthesis
Brain-Specific Functions
- High expression in [neurons](/entities/neurons) and [astrocytes](/entities/astrocytes)
- Critical for maintaining NADPH pools in brain tissue
- Supports antioxidant defense via glutathione regeneration
Role in Neurodegeneration
Alzheimer's Disease
TKT dysfunction in AD is well-characterized:
- Reduced TKT activity in AD brains (40-60% of normal) (PMID:7535719)
- Thiamine deficiency is common in AD and contributes to cognitive decline
- Impaired PPP function leads to reduced NADPH and increased oxidative stress
- TPP cofactor levels are reduced in AD brain tissue
- TKT decline correlates with disease severity
Wernicke-Korsakoff Syndrome
- TKT is highly sensitive to thiamine deficiency
- Thiamine deficiency dramatically reduces TKT activity
- Wernicke's encephalopathy involves PPP dysfunction
- Thiamine supplementation improves TKT function
Parkinson's Disease
- PPP dysfunction contributes to oxidative stress in dopaminergic neurons
- Reduced NADPH compromises glutathione antioxidant defense
- TKT activity is impaired in PD substantia nigra
- Thiamine supplementation has been explored in PD models
Diabetic Neuropathy
- TKT activity is reduced in diabetic conditions
- Hyperglycemia impairs PPP function
- Contributes to diabetic neuropathy pathogenesis
Therapeutic Implications
Thiamine and TPP Supplementation
- Thiamine (vitamin B1): Oral supplementation may improve TKT function
- Thiamine pyrophosphate (TPP): Direct cofactor supplementation
- Benfotiamine: Lipid-soluble thiamine derivative with better brain penetration
- Clinical trials have shown modest benefits in AD and diabetic neuropathy
PPP Enhancers
- Compounds that stimulate PPP flux
- NADPH-boosting strategies
- Antioxidant approaches targeting PPP dysfunction
Interaction Network
TKT interacts with:
- TKT11/TKT2: Alternative splicing isoforms
- G6PD: First enzyme of oxidative PPP branch
- 6PGL: 6-phosphogluconolactonase
- PGD: 6-phosphogluconate dehydrogenase
- RPE: Ribulose-5-phosphate 3-epimerase
- PRPS: Phosphoribosyl pyrophosphate synthetase
- GSTA1-4: Glutathione S-transferases (NADPH-dependent)
- TXN: Thioredoxin system
See Also
- [Pentose Phosphate Pathway](/mechanisms/pentose-phosphate-pathway)
- [Thiamine Deficiency](/mechanisms/thiamine-deficiency)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Wernicke-Korsakoff Syndrome](/diseases/wernicke-korsakoff-syndrome)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Oxidative Stress](/mechanisms/oxidative-stress)
- [G6PD Gene](/genes/g6pd)
- [Metabolic Therapy](/therapeutics/metabolic-therapy)
Overview
Tkt Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Tkt Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [NCBI Gene: TKT](https://www.ncbi.nlm.nih.gov/gene/7086)
- [UniProt: P29597](https://www.uniprot.org/uniprot/P29597)
- [Ensembl: ENSG00000163798](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163798)
- [GeneCards: TKT](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TKT)
References
[Gibson GE, et al, (1988) (1988)](https://pubmed.ncbi.nlm.nih.gov/7535719/)
[Calingasan NY, et al, (1995) (1995)](https://pubmed.ncbi.nlm.nih.gov/7789261/)
[Mastrogiacoma F, et al, (1996) (1996)](https://pubmed.ncbi.nlm.nih.gov/8774917/)
[Heroux M, et al, (1999) (1999)](https://pubmed.ncbi.nlm.nih.gov/10386971/)
[Park LC, et al, (1999) (1999)](https://pubmed.ncbi.nlm.nih.gov/10458917/)
[Zhou J, et al, (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21573954/)Pathway Diagram
The following diagram shows the key molecular relationships involving TKT Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)